Product NDC: | 15478-001 |
Proprietary Name: | Releev Cold Sore Treatment |
Non Proprietary Name: | Benzalkonium Chloride |
Active Ingredient(s): | 1.3 mg/mL & nbsp; Benzalkonium Chloride |
Administration Route(s): | TOPICAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 15478-001 |
Labeler Name: | Topical Pharmaceuticals Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part333A |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20060601 |
Package NDC: | 15478-001-01 |
Package Description: | 1 POUCH in 1 BLISTER PACK (15478-001-01) > 1 BOTTLE, DROPPER in 1 POUCH > 1 mL in 1 BOTTLE, DROPPER |
NDC Code | 15478-001-01 |
Proprietary Name | Releev Cold Sore Treatment |
Package Description | 1 POUCH in 1 BLISTER PACK (15478-001-01) > 1 BOTTLE, DROPPER in 1 POUCH > 1 mL in 1 BOTTLE, DROPPER |
Product NDC | 15478-001 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Benzalkonium Chloride |
Dosage Form Name | LIQUID |
Route Name | TOPICAL |
Start Marketing Date | 20060601 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Topical Pharmaceuticals Inc. |
Substance Name | BENZALKONIUM CHLORIDE |
Strength Number | 1.3 |
Strength Unit | mg/mL |
Pharmaceutical Classes |